Agricultural Inputs
Compare Stocks
5 / 10Stock Comparison
BHST vs NXRT vs GFAI vs SIGA vs XTLB
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
Security & Protection Services
Drug Manufacturers - Specialty & Generic
Biotechnology
BHST vs NXRT vs GFAI vs SIGA vs XTLB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Agricultural Inputs | REIT - Residential | Security & Protection Services | Drug Manufacturers - Specialty & Generic | Biotechnology |
| Market Cap | $95M | $758M | $11M | $337M | $358K |
| Revenue (TTM) | $33M | $252M | $72M | $95M | $451K |
| Net Income (TTM) | $-12M | $-32M | $-24M | $23M | $-1M |
| Gross Margin | 59.2% | 91.1% | 15.1% | 68.6% | 26.4% |
| Operating Margin | -18.8% | 11.5% | -27.4% | 25.1% | -481.6% |
| Forward P/E | — | — | — | 2.8x | — |
| Total Debt | $14M | $1.56B | $3M | $795K | $138K |
| Cash & Equiv. | $2M | $14M | $22M | $154.97T | $371K |
BHST vs NXRT vs GFAI vs SIGA vs XTLB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 24 | May 26 | Return |
|---|---|---|---|
| BioHarvest Sciences… (BHST) | 100 | 88.8 | -11.2% |
| NexPoint Residentia… (NXRT) | 100 | 71.7 | -28.3% |
| Guardforce AI Co., … (GFAI) | 100 | 47.5 | -52.5% |
| SIGA Technologies, … (SIGA) | 100 | 65.1 | -34.9% |
| XTL Biopharmaceutic… (XTLB) | 100 | 36.3 | -63.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BHST vs NXRT vs GFAI vs SIGA vs XTLB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BHST ranks third and is worth considering specifically for growth exposure.
- Rev growth 98.8%, EPS growth 14.0%, 3Y rev CAGR 128.8%
- 98.8% revenue growth vs XTLB's -173.2%
NXRT is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- Beta 0.62 vs GFAI's 2.31
- 7.1% yield, 12-year raise streak, vs SIGA's 12.8%, (3 stocks pay no dividend)
GFAI lags the leaders in this set but could rank higher in a more targeted comparison.
SIGA carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 7.2% 10Y total return vs NXRT's 211.0%
- Lower volatility, beta 1.15, Low D/E 0.0%, current ratio 11.83x
- Beta 1.15, yield 12.8%, current ratio 11.83x
- Better valuation composite
Among these 5 stocks, XTLB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 98.8% revenue growth vs XTLB's -173.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 24.6% margin vs XTLB's -227.7% | |
| Stability / Safety | Beta 0.62 vs GFAI's 2.31 | |
| Dividends | 7.1% yield, 12-year raise streak, vs SIGA's 12.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +0.6% vs GFAI's -52.0% | |
| Efficiency (ROA) | 0.0% ROA vs GFAI's -50.2%, ROIC 0.0% vs -41.6% |
BHST vs NXRT vs GFAI vs SIGA vs XTLB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
BHST vs NXRT vs GFAI vs SIGA vs XTLB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SIGA leads in 4 of 6 categories
NXRT leads 1 • BHST leads 0 • GFAI leads 0 • XTLB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SIGA leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NXRT is the larger business by revenue, generating $252M annually — 557.9x XTLB's $451,000. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to XTLB's -2.3%. On growth, BHST holds the edge at +38.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $33M | $252M | $72M | $95M | $451,000 |
| EBITDAEarnings before interest/tax | -$5M | $125M | -$12M | $24M | -$1M |
| Net IncomeAfter-tax profit | -$12M | -$32M | -$24M | $23M | -$1M |
| Free Cash FlowCash after capex | -$10M | $79M | -$6M | $49M | $0 |
| Gross MarginGross profit ÷ Revenue | +59.2% | +91.1% | +15.1% | +68.6% | +26.4% |
| Operating MarginEBIT ÷ Revenue | -18.8% | +11.5% | -27.4% | +25.1% | -4.8% |
| Net MarginNet income ÷ Revenue | -36.3% | -12.7% | -32.9% | +24.6% | -2.3% |
| FCF MarginFCF ÷ Revenue | -30.8% | +31.2% | -8.8% | +51.5% | -3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +38.7% | +0.5% | +3.6% | -95.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +12.5% | 0.0% | +38.9% | -111.8% | +20.0% |
Valuation Metrics
SIGA leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $95M | $758M | $11M | $337M | $357,581 |
| Enterprise ValueMkt cap + debt − cash | $107M | $2.3B | -$8M | -$154.97T | $124,581 |
| Trailing P/EPrice ÷ TTM EPS | -5.25x | -23.69x | -0.94x | 14.24x | -0.34x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 2.76x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 18.61x | — | -6387033.21x | — |
| Price / SalesMarket cap ÷ Revenue | 3.78x | 3.01x | 0.30x | 3.56x | 0.79x |
| Price / BookPrice ÷ Book value/share | 51.14x | 2.52x | 0.17x | 0.00x | 0.07x |
| Price / FCFMarket cap ÷ FCF | — | 9.06x | — | 6.91x | — |
Profitability & Efficiency
SIGA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SIGA delivers a 0.0% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-12 for BHST. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BHST's 10.39x. On the Piotroski fundamental quality scale (0–9), BHST scores 6/9 vs XTLB's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.0% | -10.1% | -69.7% | 0.0% | -25.5% |
| ROA (TTM)Return on assets | -41.5% | -1.7% | -50.2% | 0.0% | -17.7% |
| ROICReturn on invested capital | -70.4% | +1.1% | -41.6% | +0.0% | -54.1% |
| ROCEReturn on capital employed | -65.1% | +1.5% | -19.1% | 0.0% | -50.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 6 | 5 | 3 |
| Debt / EquityFinancial leverage | 10.39x | 5.18x | 0.08x | 0.00x | 0.03x |
| Net DebtTotal debt minus cash | $11M | $1.5B | -$19M | -$154.97T | -$233,000 |
| Cash & Equiv.Liquid assets | $2M | $14M | $22M | $154.97T | $371,000 |
| Total DebtShort + long-term debt | $14M | $1.6B | $3M | $795,169 | $138,000 |
| Interest CoverageEBIT ÷ Interest expense | -1.10x | 0.47x | -167.24x | — | -13.31x |
Total Returns (Dividends Reinvested)
SIGA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SIGA five years ago would be worth $10,096 today (with dividends reinvested), compared to $49 for GFAI. Over the past 12 months, SIGA leads with a +0.6% total return vs GFAI's -52.0%. The 3-year compound annual growth rate (CAGR) favors SIGA at 6.8% vs GFAI's -59.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -19.4% | +2.7% | -22.2% | -15.5% | +35.4% |
| 1-Year ReturnPast 12 months | -35.9% | -15.5% | -52.0% | +0.6% | -43.6% |
| 3-Year ReturnCumulative with dividends | -16.0% | -15.4% | -93.5% | +21.7% | -33.9% |
| 5-Year ReturnCumulative with dividends | -16.0% | -21.7% | -99.5% | +1.0% | -76.3% |
| 10-Year ReturnCumulative with dividends | -16.0% | +211.0% | -99.5% | +722.2% | -84.5% |
| CAGR (3Y)Annualised 3-year return | -5.6% | -5.4% | -59.7% | +6.8% | -12.9% |
Risk & Volatility
NXRT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NXRT is the less volatile stock with a 0.62 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXRT currently trades 77.9% from its 52-week high vs XTLB's 31.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.62x | 2.31x | 1.15x | 1.71x |
| 52-Week HighHighest price in past year | $12.80 | $38.30 | $1.50 | $9.62 | $10.28 |
| 52-Week LowLowest price in past year | $4.10 | $23.79 | $0.38 | $4.29 | $1.05 |
| % of 52W HighCurrent price vs 52-week peak | +32.8% | +77.9% | +33.2% | +48.9% | +31.6% |
| RSI (14)Momentum oscillator 0–100 | 43.1 | 69.2 | 51.2 | 44.0 | 67.4 |
| Avg Volume (50D)Average daily shares traded | 23K | 219K | 405K | 683K | 2.4M |
Analyst Outlook
Evenly matched — NXRT and SIGA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BHST as "Buy", NXRT as "Hold", SIGA as "Buy". Consensus price targets imply 138.1% upside for BHST (target: $10) vs -9.5% for NXRT (target: $27). For income investors, SIGA offers the higher dividend yield at 12.81% vs NXRT's 7.06%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | — | Buy | — |
| Price TargetConsensus 12-month target | $10.00 | $27.00 | — | — | — |
| # AnalystsCovering analysts | 1 | 10 | — | 1 | — |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% | — | +12.8% | — |
| Dividend StreakConsecutive years of raises | — | 12 | — | 4 | — |
| Dividend / ShareAnnual DPS | — | $2.11 | — | $0.60 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.0% | 0.0% | 0.0% | 0.0% |
SIGA leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). NXRT leads in 1 (Risk & Volatility). 1 tied.
BHST vs NXRT vs GFAI vs SIGA vs XTLB: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is BHST or NXRT or GFAI or SIGA or XTLB a better buy right now?
For growth investors, BioHarvest Sciences Inc.
Common Stock (BHST) is the stronger pick with 98. 8% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate BioHarvest Sciences Inc. Common Stock (BHST) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — BHST or NXRT or GFAI or SIGA or XTLB?
Over the past 5 years, SIGA Technologies, Inc.
(SIGA) delivered a total return of +1. 0%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — BHST or NXRT or GFAI or SIGA or XTLB?
By beta (market sensitivity over 5 years), NexPoint Residential Trust, Inc.
(NXRT) is the lower-risk stock at 0. 62β versus Guardforce AI Co. , Limited's 2. 31β — meaning GFAI is approximately 271% more volatile than NXRT relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 10% for BioHarvest Sciences Inc. Common Stock — giving it more financial flexibility in a downturn.
04Which is growing faster — BHST or NXRT or GFAI or SIGA or XTLB?
By revenue growth (latest reported year), BioHarvest Sciences Inc.
Common Stock (BHST) is pulling ahead at 98. 8% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: Guardforce AI Co. , Limited grew EPS 88. 3% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, BHST leads at 128. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — BHST or NXRT or GFAI or SIGA or XTLB?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus -227. 7% for XTL Biopharmaceuticals Ltd. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -481. 6% for XTLB. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is BHST or NXRT or GFAI or SIGA or XTLB more undervalued right now?
Analyst consensus price targets imply the most upside for BHST: 138.
1% to $10. 00.
07Which pays a better dividend — BHST or NXRT or GFAI or SIGA or XTLB?
In this comparison, SIGA (12.
8% yield), NXRT (7. 1% yield) pay a dividend. BHST, GFAI, XTLB do not pay a meaningful dividend and should not be held primarily for income.
08Is BHST or NXRT or GFAI or SIGA or XTLB better for a retirement portfolio?
For long-horizon retirement investors, NexPoint Residential Trust, Inc.
(NXRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62), 7. 1% yield, +211. 0% 10Y return). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXRT: +211. 0%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BHST and NXRT and GFAI and SIGA and XTLB?
These companies operate in different sectors (BHST (Basic Materials) and NXRT (Real Estate) and GFAI (Industrials) and SIGA (Healthcare) and XTLB (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BHST is a small-cap high-growth stock; NXRT is a small-cap income-oriented stock; GFAI is a small-cap quality compounder stock; SIGA is a small-cap deep-value stock; XTLB is a small-cap quality compounder stock. NXRT, SIGA pay a dividend while BHST, GFAI, XTLB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.